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SUM M ARY
The effect o f  the deg ree  o f  sheep  red cell sensitisa tion  by an tibody in the resistance  to lysis by sheep and horse  com plem ent w as analysed. 
The results show ed that, as ihe level o f  sensitisa tion  increased , so did the hom ologous com plem ent activ ity , even tually  leading  to  one hundred 
percent o f lysis; the sam e w as observed  for horse  serum , generally  considered  as not effic ient at lysing these cells. T herefore, the hom ologous 
anil he tero logous restriction  can  be overridden  by this treatm ent. T h is  may be o f  in terest for the com prehension  o f  the m echan ism s involved 
in the m odulation  o f  the restric tion  phenom enon in health  an in d iseases involv ing  com plem ent in dom estic  anim als and in hum an, as w ell as 
in laboratory d iagnosis w here hem oly tic  assays are used  for m easurem ent o f  com plem ent activity  and evaluation  o f  p resence o f  an tibod ies in 
serum  sam ples.
UNITKRMS: L ysis: E rythrocytes; A ntibod ies: H em olysis
INTRODUCTION
Com plem ent is not eff icient at lysing erythrocytes from 
the same species. Membrane proteins regulate the C3 eon- 
vertase71- and the membrane attack complex (M A C )1719, 
restricting com plem ent activity. E rythrocytes from indi­
viduals affected by paroxysmal nocturnal hemoglobinuria 
are defficient in Decay A ccelera ting  Factor  ( D A F ) 1-1-14, 
H om ologous  R estr ic tion  F ac to r  (H F R )518, and C D 5 9 8, 
and  a re  s u s c e p t i b l e  to  h o m o l o g o u s  c o m p l e m e n t .  
Resistance to complement action is also observed in het­
erologous systems, depending on the cell and o f  species o f  
complement. As an example, horse com plem ent is ineffi­
cient to lyse sheep red cells - - 1 i-12, and control o f  the MAC 
is involved11. However, this restriction appears to be tem ­
porary. S torage  in v itro  inc reases  the su scep t ib i l i ty  o f  
sheep red cells to horse com plem en t1, and human cells to 
human com plem en t10. This may partially explain oppos­
ing results in the literature9-1-'’, and iluslrates the im por­
tance of  studies analysing possible factors involved in this 
phenomenon.
In studies employing sheep serum, inconsistent results were 
observed using different lots o f  the same monoclonal anti­
body to sensitise sheep red cells '.  The level of cell sensitisa­
tion is known to interfere in the degree o f  lysis, but its corre­
lation to the homologous (and heterologous) restriction to 
complement has not been focalized. Here sheep erythrocytes
were sensitised with variable amounts o f  antibody and sub­
jected to lysis by sheep (homologous) and horse (heterolo­
gous) serum; guinea pig and human serum were used for 
comparison. The results are discussed in terms of  degree of 
restriction presented by these sensitised cell to complement 
action. The importance of studies on this subject is rein­
forced considering situations of occurrence of high levels of 
antibodies and cell sensitisation in Wvo^, (he cytolitic reac­
tions by homologous complement4, and its role in immune 
surveillance and disease.
MATERIAL AND METHOD
Complement Fixation Diluent (CFD) containing Ca-+. Mg2+ 
and 0.1% gelatin; and phosphate-buffered saline (PBS) were 
prepared as described6. Two aliquots o f  blood were collected 
under sterile conditions from each adult healthy sheep: in 4% 
sodium citrate for the cells, and without anticoagulant for the 
serum. Human, horse and guinea pig sera were prepared from 
blood of adult healthy individuals, pooled and stored at 70°C. 
When necessary, sera were absorbed at 0°C with sheep red 
cells. Rat monoclonal ( IgM ) anti-sheep red cell antibody was 
s u p p l i e d  by th e  M R C  C e n t r e ,  C a m b r id g e ,  E n g la n d .  
Polyclonal (mainly IgG) anti-sheep red cell antibody was 
prepared by injecting rabbits with cell stroma, collecting 
serum, and inactivating it at 56°C for 30 minutes. Hemolytic
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assays were performed incubating 40 pi o f  EA with scrum 
diluted 1:2 in CFD to 1.0 ml. After 30 minutes of incubation 
at 37"C. and centrifugation, lysis was determ ined by the 
absorption of  the supernatant at 412 nm. Percentages of  lysis 
were calculated considering the absorption of  EA lysed in 
distilled water as 100%. Dilutions of  monoclonal antibody 
used to EA preparation offered approximately 8.4 x 10! - 5.4 
x 10s molecules o f  antibody/cell.
RESULTS ANI) DISCUSSION
Sheep erythrocytes from one animal were washed in PBS 
and sensit ised  with var ious  co n c en tra t io n s  o f  an t ibody  
(Erythrocyte-Antibody complex. EA) according to HARRI­
SON: LACH M A NN 6 (1986), washed 3 times in CFD, and 
resuspended to a concentration of 1.7 x 10* cells/ml. The EA 
were incubated at 37°C with sheep serum from the same ani­
mal or horse serum from a pool, and lysis was measured 
after 30 minutes. The results o f  a representa tive  from 4 
assays arc shown in Fig. 1. At adequate antibody concentra­
tion. the sheep serum lysed one hundred  percent o f  the 
autologous cells, and the same occurred for horse serum. 
Fresh cells were used to abrogate age-related variations in 
susceptibility to com plem ent1. Therefore, homologous and 
heterologous restriction to lysis by complement can be over­
ridden by this treatment. Similarly, reactive lysis by homolo­
gous complement was observed when the number of  C'5b67 
sites was sufficiently increased, compensating the lysis inhi­
bition17. The effect was similar with both monoclonal and 
polyclonal antibodies, indicating that it is not specific to a 
par t icu lar  an t ibody  or, for the po lyc lonal  an t ise rum , to 
blockage of  restricting factors on the cell membrane. The 
use of  one serum dilution throughout the experiment, and 
the absence of  lysis by inactivated sera (not shown) elimi­
nate the possibility o f  interference of  factors other than com­
plement in the results.
Data in Tab. I (representative from 4 assays) there is a com ­
parison of lysis of EA by sheep, horse, human and guinea 
pig com plem ent,  c learly  showing the high eff ic iency of  
human and guinea pig serum in this system. However, simi­
larly to data in Fig. 1. sheep and horse serum diluted 1 in 2 
lysed the cells at the appropriate antibody concentration. In 
this assay, the use of  antibody diluted only 1 in 32 or 1 in 64 
would lead conversely to the conclusion that the activity of 
re sp e c t iv e ly  sh eep  or  sh e ep  and horse  c o m p le m e n t  is 
absolutely restricted by sheep red cells.
Lysis by homologous complement in vitro was observed to 
human red cells sensitised by an t ibody10, however it peaked 
at levels o f  40-60%, with routinely lower values (less than
35%). Our results complement these observations showing 
that, one hundred percent of hom ologous lysis occurs in 
vitro  since cells are heavily sensitised. Thus, the level of 
sensitising antibody affects the restriction presented by cells 
to com plem ent attack and may have an important role in 
defense and disease mechanisms. High sensitisation ol cells 
may occur in vivo  in some cases leading to severe hemoly­
sis or cell death. This is ilustralcd by the occurrence of 
cytolytic reactions by hom ologous com plem ent,  such as 
destruction of cat cells infected with feline leukemia virus 
by ca t a n t i - tu m o r  IgG and cat c o m p le m e n t1: or severe 
hem olysis  associa ted  with pathological processes where 
high levels o f  antibodies and cell sensitisation occurs in 
vivo, as in cold agglutinin syndrom e in h u m a n s '6. Apart 
from this, they may have interest also for the routine use of 
sensitised sheep erythrocytes in hemolytic assays for labo­
ratory diagnosis involving determination of antibody titres 
or com plem ent levels; particularly  considering  here the 
large domesticated animals, whose sera show low lytic effi­
ciency against these cells-1, and the possibility of improve­
ment o f  assay sensitivity by increasing the level o f  cell sen­
sitisation.
The mechanism by which high levels o f  antibody sensitisa­
tion overcome homologous restriction is not clear. It is pos­
sible that enhanced  rates o f  com plem ent activation may 
allow MAC formation to occur sufficiently rapid to avoid 
the action o f  the restriction proteins. Further investigation ol 
the mechanism is therefore in progress.
CONCLUSIONS
Our results show that the level of cell sensitisation affect'- 
hom ologous  (and hetero logous)  restric tion  presented b\ 
cells to complement attack. This may help the comprehen­
sion of the mechanisms underlying the modulation of (he 
restriction phenomenon as well as its role in determining 
complement action in defense and diseases. In addition, or 
using hemolytic assays for research and laboratorial diagno­
sis, one has to be aw are  that an t ibody  titres may v a n  
depending on the complement source used in the titratior 
assays, and that in some cases lest sensitivity for measuring 
complement levels can be improved by increasing cell sensi­
tisation. This  may be important in veterinary pathology 
since, as previously stated, serum from most common large 
domestic animals do not Ivse sheep cells, and there is. it 
consequence, little information on their complement le\el; 
in health and in disease*.
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FKil'Rl-: I
Litfeci o f  the deg ree  o f  cell sensitisa tion  b \  an tibody  in the lysis  o f  sheep  
F.A b \ sheep  (O ) and horse (O ) sera.
F.A w ere incubated  at 37°C lo r 30  m inu tes  w ith  d ilu ted  serum . A fte r c en ­
trifugation . I \s is  w as de te rm in ed  by the ab so rp tion  o f  the supernalen t at 
412 m m , c o n s id e rin g  the  a b so rp tio n  o f  KA ly sed  in d is tille d  w a te r as 
100#.
TABI.F. 1
P ercen tage  o f  lysis o f  sheep  F^ A (m onoclonal an tibody) by sheep, horse 
hum an o r gu inea pig serum *. R ibeirão  P reto  - SP , 1993.
R eciprocals 
o f  antibody 
dilu tions 
C om plem ent 
Source *“
*> 4 8 l(> .Í2 64
hum an KKI.O KKI.O 100.0 100.0 KKI.O lOO.O
g u inea  pig 100.0 100.0 100.0 KKI.O KKI.O KKI.O
equine 100.0 100.0 100.0 97.6 26. 1 0.0
sheep 100.0 88.4 52.9 14.9 (1.0 0 .0
* The hem olytic assay  w as preform ed as in Fig. 1.
** C om plem ent w as d ilu ted  1:2 in CT'I) (see m ethods for diluent com posi 
lion).
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R K S U M O
Neste trabalho foi analisado o eleito do grau de sensibilização de hetruíeias de carneiro por anticorpo, na resistência à lise pelo 
complemento do soro eqüino e de carneiro. Os resultados mostraram que, à medida que houve 11111 aumento do nível de sensi­
bilização. ocorreu também 11111 aumento da atividade do complemento homólogo, levando a 1009; de lise: o mesmo foi obser­
vado para o complemento do soro eqüino, geralmente considerado ineficiente na lise destas células. A restrição à lise pode. 
assim, ser sobrepujada por este tratamento. listes dados podem ser de interesse para a compreensão dos mecanismos envolvi­
dos na modulação do fenômeno de restrição, na saúde e etn doenças envolvendo o sistema complemento em animais domésti­
cos c 110 homem, bem como em diagnóstico laboratorial, onde são utilizados ensaios hemolíticos para medida de atividade do 
complemento e pesquisa de anticorpos em amostras de soro.
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